Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

cDNA microarray-based translational research in soft tissue sarcoma.

Joanna M Lubieniecka, Torsten O Nielsen

    Journal of Surgical Oncology
    |November 22, 2005
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Synovial sarcoma reprograms transcription by GBAF activation of polycomb targets and loss of CBAF enhancers.

    Nature communications·2025
    Same author

    The fibroblast epigenome underlies SS18::SSX-mediated transformation in synovial sarcoma.

    Nature communications·2025
    Same author

    Chromobox 4 (CBX4) Is a Novel Interactor of SS18::SSX in Synovial Sarcoma.

    Laboratory investigation; a journal of technical methods and pathology·2025
    Same author

    Molecular and epigenetic oncogenesis in synovial sarcoma: implications for cancer biology, diagnosis and treatment.

    Oncogene·2025
    Same author

    Mycophenolic acid treatment drives the emergence of novel SARS-CoV-2 variants.

    Proceedings of the National Academy of Sciences of the United States of America·2025
    Same author

    DNA demethylating agents suppress preclinical models of synovial sarcoma.

    The Journal of clinical investigation·2025
    Same journal

    Institutional Learning Curve in Esophagectomy: Technical Standardization of Gastric Conduit Formation and Conduit-Related Outcomes in 187 Consecutive Patients.

    Journal of surgical oncology·2026
    Same journal

    Evaluating the Accuracy of ChatGPT-4o in Addressing Complex Clinical Questions Based on NCCN Guidelines for Rectal Adenocarcinoma.

    Journal of surgical oncology·2026
    Same journal

    Racial Differences in Breast Cancer Treatment and Information Access.

    Journal of surgical oncology·2026
    Same journal

    Comparative Analysis of CEM and Breast MRI: A Retrospective Study.

    Journal of surgical oncology·2026
    Same journal

    The Treatment Efficacy for Patients Undergoing Combined Transanal-Transabdominal Endoscopic Resection of Rectal Anastomosis Stenosis.

    Journal of surgical oncology·2026
    Same journal

    "It Depends on the Situation": Variability in How Surgical Oncologists Elicit and Integrate Patient Values.

    Journal of surgical oncology·2026
    See all related articles

    Complementary DNA (cDNA) microarray technology aids translational research in identifying diagnostic markers and therapeutic targets for adult soft tissue sarcoma. Synovial sarcoma studies demonstrate its utility, emphasizing preclinical validation needs.

    Area of Science:

    • Biotechnology
    • Oncology
    • Translational Research

    Background:

    • cDNA microarray technology offers a powerful approach for high-throughput gene expression profiling.
    • Translational research aims to bridge the gap between basic science discoveries and clinical applications.

    Discussion:

    • Application of cDNA microarray technology in adult soft tissue sarcoma research.
    • Identification of diagnostic markers and therapeutic targets using gene expression data.
    • Case study on synovial sarcoma to illustrate marker and target discovery.

    Key Insights:

    • cDNA microarrays are effective for discovering potential diagnostic markers in soft tissue sarcomas.
    • This technology can identify novel therapeutic targets for sarcoma treatment.
    • Synovial sarcoma serves as a relevant model for demonstrating the technology's potential.

    Related Experiment Videos

    Outlook:

    • Preclinical validation is crucial for therapeutic targets identified via cDNA microarrays.
    • Further research is needed to translate microarray findings into clinical practice.
    • Advancements in microarray technology may enhance sarcoma diagnostics and therapeutics.